Stryker Expands Neuro Line With Synergetics Portfolio Buy

Stryker added to its neuro device mix with the acquisition of Synergetics USA's portfolio, leaving the firm's ophthalmic device line with Valeant Pharmaceuticals.

Stryker Corp. made a move to expand into the neurosurgical market on Feb. 10 with an agreement to acquire all of the assets in Synergetics USA Inc.’s neurological portfolio. The portfolio, which includes the Malis generator, Spetzler Malis disposable forceps, and Stryker`s existing Sonopet tips and RF generator, racked up about $31 million in worldwide sales in 2015.

“The acquisition of the Synergetics neuro portfolio is highly complementary to Stryker Instruments' Neuro Spine & ENT business, and is aligned with NSE's strategy of expanding its neurosurgical product offering,"...

More from Deals

More from Business